RESTON, VA – The Journal of Nuclear Medicine (JNM)–the flagship publication of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)–has again been ranked among the top medical imaging journals worldwide, according to new data just released in the 2017 Journal Citation Reports© published by Clarivate Analytics.
JNM’s impact factor increased 12%, from 6.646 (2016) to 7.439 (2017), and the journal ranked fifth in impact factor of the 128 journals included in the medical imaging category. JNM’s five-year impact factor is 6.893, up from 6.459 the previous year. Citations to the journal increased from 24,977 to 27,101, and JNM’s article influence score is 1.852.
“JNM’s increasing impact factor demonstrates the journal’s influential role in molecular imaging, and we are honored that it is the journal of choice for many distinguished researchers,” said Editor-in-Chief Johannes Czernin, MD, professor of molecular and medical pharmacology and chief of the Ahmanson Translational Imaging Division at the UCLA David Geffen School of Medicine, Los Angeles, California. “Among nuclear medicine journals, JNM continues to have the highest number of citations, the highest average 5-year impact factor, the highest number of citable articles, and the highest influence score.”
He pointed out, “As this impact factor is
Article originally posted at